Signant Health

Signant Health Partner with Signant for science-led solutions to digitalize and optimize clinical trial protocols.

Complex designs such as adaptive basket or umbrella trials are making RTSM builds more challenging. This blog covers bes...
07/10/2025

Complex designs such as adaptive basket or umbrella trials are making RTSM builds more challenging. This blog covers best practices for implementation of adaptive trials: https://hubs.li/Q03wDN2F0

07/03/2025

Supply shortages trigger expensive emergency manufacturing and can halt patient enrollment. Our Forecasting & Planning solution leverages real-time supply usage data and sophisticated predictive algorithms to model a range of study scenarios, identifying potential supply constraints months in advance and enabling timely production adjustments. Stay ahead of demand with Signant’s Forecasting and Planning, built for clinical trials. Explore the solution:
https://hubs.li/Q03vMBFr0

Signant's operations team has been named a finalist for the prestigious OnCon Icon Top 100 Operations Team Award. This r...
07/01/2025

Signant's operations team has been named a finalist for the prestigious OnCon Icon Top 100 Operations Team Award. This recognition underscores our commitment to operational excellence as a catalyst for clinical research advancement.

By continuously refining our processes and investing in innovative solutions, we help clinical trials generate the robust data necessary for successful drug approvals.

👉Show your support for a team driving clinical research forward (scroll down to "S" to find Signant Health): https://hubs.li/Q03vtsr10

When choosing an eClinical partner, biotechs and emerging biopharma shouldn’t have to choose between working with an est...
06/26/2025

When choosing an eClinical partner, biotechs and emerging biopharma shouldn’t have to choose between working with an established, full-service company and a provider with a hands-on approach. Get the best of both worlds: https://hubs.li/Q03tQFnz0

06/24/2025

Running GLP-1 RA trials? Our ePRO handles the complexities – from dose escalation tracking and cardiovascular assessments to participant retention. Streamline your data capture and engagement strategy: https://hubs.li/Q03tmcnQ0

06/18/2025

Our new "Getting Started with eCOA" series is your go-to resource for mastering the essentials of electronic COAs. Explore our quick-read guides and get the insights you need to succeed. Check it out now: https://hubs.li/Q03sH8sb0

🚀 Our TrialMax® platform features automation for the Data Change Form (DCF) process, streamlining study management like ...
06/11/2025

🚀 Our TrialMax® platform features automation for the Data Change Form (DCF) process, streamlining study management like never before. By automating DCFs, we reduce manual efforts, minimize errors, and speed up data management. Learn how TrialMax® is revolutionizing study delivery: https://hubs.li/Q03rHZ2w0

How might placebo response and expectation bias impact   outcomes? How can they be mitigated to ensure data reliability?...
06/10/2025

How might placebo response and expectation bias impact outcomes? How can they be mitigated to ensure data reliability? Get answers from experts here:
https://hubs.li/Q03rr6D00

06/03/2025

Leading technology without limits: Global pharmaceutical leaders rely on our comprehensive , eClinRO, and solutions for reliable evidence generation. No surprises, just flexible tech backed by expert teams. Explore industry-standard solutions: https://hubs.li/Q03qqxlP0

Sites using too many systems? Our EDC offers add-on modules for eCOA, eConsent, and Randomization. One platform, one log...
05/30/2025

Sites using too many systems? Our EDC offers add-on modules for eCOA, eConsent, and Randomization. One platform, one login, and happy sites. Take a look:
https://hubs.li/Q03p_DKQ0

The placebo effect is a contributing factor in the low success rates of novel pain medication  , where less than 5% of l...
05/30/2025

The placebo effect is a contributing factor in the low success rates of novel pain medication , where less than 5% of low-abuse potential drugs gain approval. See how we helped one pharma company limit placebo effect with our placebo response mitigation solutions, and gain FDA approval: https://hubs.li/Q03pXkQp0

With our novel patient-reported outcome measure, PROMIS CAT, study teams can capture precise data from fewer questions o...
05/29/2025

With our novel patient-reported outcome measure, PROMIS CAT, study teams can capture precise data from fewer questions or items, reducing completion burden for patients. Bonus: Incorporate it alongside traditional COAs. Get details: https://hubs.li/Q03pHj5d0

Address

Philadelphia, PA

Alerts

Be the first to know and let us send you an email when Signant Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share